Hemp Foods and THC Levels:

A Scientific Assessment
by Franjo Grotenhermen, M.D., Michael Karus, and Daike Lohmeyer
Part II (continued)

6 Literature

Abel, E. L.: Prenatal exposure to Cannabis: a critical review of effects on growth, development, and behaviour. Behav. Neural. Biol. (1980) 29:137-156.

Abel, E. L.: Marihuana and sex: a critical survey. Drug Alcohol Depend. (1981) 8:1-22.

Abel, E. L.: Effects of delta 9-THC on pregnancy and offspring in rats. Neurobehav. Toxicol. Teratol. (1984) 6:29-32.

Abel, E. L.: Effects of prenatal exposure to cannabinoids. NIDA Res. Monogr. (1985) 59:20-35.

Abel, E. L., Dintcheff, B. A.: Increased marihuana-induced fetotoxicity by a low dose of concomitant alcohol administration. J. Stud. Alcohol (1986) 47:440-443.

Abrahamov, A., Abrahamov, A., Mechoulam, R.: An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. (1995) 56:2097-2102.

Abrams, R. M., Cook, C. E., Davis, K. H., Niederreither, K., Jaeger, M. J., Szeto, H. H.: Plasma delta-9-tetrahydrocannabinol in pregnant sheep and fetus after inhalation of smoke from a marijuana cigarette. Alcohol Drug Res. (1985-1986) 6:361-369.

Agurell, S., Halldin, M., Lindgren, J. E., Ohlsson, A., Widman, M., Gillespie, H., Hollister, L.: Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev (1986) 38:21-43.

Allentuck, S.: Medical aspects. In: Cattell, J. (ed.): The Marijuana Problem in the City of New York. Ronald Press, New York 1944, p. 35-64. Reprinted in: Mikuriya, T. H. (ed.): Marjuana: Medical Papers 1839-1972. Medi-Comp Press, Oakland 1973.

Alt, A., Reinhardt, G.: Speiseöle auf Hanfbasis und ihr Einfluß auf die Ergebnisse von Urin- und Blutanalysen. Blutalkohol (1996) 33:347-356.

Alt, A., Reinhardt, G.: Nahrungsmittel auf Hanfbasis und deren forensische Bedeutung. Blutalkohol (1997) 34:286-293.

Asch, R. H., Smith, C. G.: Effects of delta 9-THC, the principal psychoactive component of marijuana, during pregnancy in the rhesus monkey. J. Reprod. Med. (1986) 31:1071-1081.

Ashfaq, M. K., Watson, E. S., elSohly, H. N.: The effect of subacute marijuana smoke inhalation on experimentally induced dermonecrosis by S. aureus infection. Immunopharmacol. Immunotoxicol. (1987) 9:319-331.

Astley, S.: Analysis of facial shape in children gestationally exposed to marijuana, alcohol and/or cocaine. Pediatrics (1992) 89:67-77.

Baczynsky, W. O., Zimmerman, A. M.: Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. I. In vivo investigation of the primary and secondary immune response. Pharmacology (1983) 26:1-11.

BAG: Verwendung von Hanf in Lebensmitteln und Gebrauchsgegenständen. Abteilung Lebensmittelrecht des Bundesamtes für Gesundheit der Schweiz, Kreisschreiben Nr. 2 vom 13.3.1996.

Bailey, J. R., Cunny, H. C., Paule, M. G., Slikker, W., Jr.: Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol. Appl. Pharmacol. (1987) 90:315-321.

Baker, P. B., Taylor, B. J., Gough, T. A.: The tetrahydrocannabinol and tetrahydrocannabinolic acid content of Cannabis products. J. Pharm. Pharmacol. (1981) 33:369-372.

Banerjee, B. N., Sofia, R. D., Erikson, D., Ivins, N. J.: Toxicity of delta 9-tetrahydrocannabinol (THC) administered subcutaneously for 13 days to female rabbits. J. Toxicol. Environ. Health (1976) 1:769-776.

Barr, H. M., Streissguth, A. P., Martin, D. C., Herman, C. S.: Infant size at 8 months of age: relationship to maternal use of alcohol, nicotine, and caffeine during pregnancy. Pediatrics (1984) 74:336-341.

Bast, G. E.: Influence of solubility and permeant size on absorption and metabolism of xenobiotics in rabbit skin. Hum. Exp. Toxicol. (1997) 16:435-440.

Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., Shepard, K. V.: Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J. Pain Symptom. Manage. (1995) 10:89-97.

Behnke, M., Eyler, F. D.: The consequences of prenatal substance use for the developing fetus, newborn, and young child. Int. J. Addict. (1993) 28:1341-1391.

Bell, R., Taylor, E. H., Ackerman, B., Pappas, A. A.: Interpretation of urine quantitative 11-nor-delta-9 tetrahydrocannabinol-9-carboxylic acid to determine abstinence from marijuana smoking. J. Toxicol. Clin. Toxicol. (1989) 27:109-115.

Belue, R. C., Howlett, A. C., Westlake, T. M., Hutchings, D. E.: The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. (1995) 17:25-30.

Berti, J. J., Lipsky, J. J.: Transcutaneous drug delivery: a practical review. Mayo Clin. Proc. (1995) 70:581-586.

Birmingham, M. K., Bartova, A.: Effects of cannabinol derivatives on blood pressure, body weight, pituitary-adrenal function, and mitochondrial respiration in the rat. In: Nahas, G. G., et al. (eds.): Marihuana: chemistry, biochemistry, and cellular effects. Springer, New York 1976. p. 425-438.

Blackard, C., Tennes, K.: Human placental transfer of cannabinoids. N. Engl. J. Med. (1984) 311:797.

Blanchard, D. K., Newton, C., Klein, T. W., Stewart, W. E., 2d., Friedman, H.: In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells. Int. J. Immunopharmacol. (1986) 8:819-824.

Bloch, E.: Effects of marijuana and cannabinoids on reproduction, endocrine function, development and chromosomes. In: Fehr, K. O., Kalant, H. (eds.): Cannabis and Health Hazards. Addiction Research Foundation, Toronto 1983.

Block, R. I., Farinpour, R., Schlechte, J. A.: Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend. (1991) 28:121-128.

Bradley, S. G., Munson, A. E., Dewey, W. L., Harris, L. S.: Enhanced susceptibility of mice to combinations of delta 9-tetrahydrocannabinol and live or killed gram-negative bacteria. Infect. Immun. (1977) 17:325-329.

Brenneisen, R.: Psychotrope Drogen. II. Bestimmung der Cannabinoide in Cannabis sativa L. und in Cannabisprodukten mittels Hochdruckflüssigkeitschromatographie (HPLC). Pharm. Acta Helv. (1984) 59:247-259.

Brenneisen, R., Egli, A., Elsohly, M. A., Henn, V., Spiess, Y.: The effect of orally and rectally administered delta 9- tetrahydrocannabinol on spasticity: a pilot study with 2 patients. Int. J. Clin. Pharmacol. Ther. (1996) 34:446-452.

Cabral, G. A., Mishkin, E. M., Marciano-Cabral, F., Coleman, P., Harris, L., Munson, A. E.: Effect of delta 9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig. Proc. Soc. Exp. Biol. Med. (1986) 182:181-186.

Cabral, G. A., Lockmuller, J. C., Mishkin, E. M.: Delta 9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse. Proc. Soc. Exp. Biol. Med. (1986b) 181:305-311.

Cabral, G. A., McNerney, P. J., Mishkin, E. M.: Delta-9-tetrahydrocannabinol inhibits the splenocyte proliferative response to herpes simplex virus type 2. Immunopharmacol. Immunotoxicol. (1987) 9:361-370.

Cabral, G. A., Mishkin, E. M.: Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators. J. Toxicol. Environ. Health (1989) 26:175-182.

Cabral, G. A., Vasquez, R.: Effects of marijuana on macrophage function. Adv. Exp. Med. Biol. (1991) 288:93-105.

Callaway J. C., Weeks, R. A., Raymon, L. P., Walls, H. C., Hearn, W. L.: A positive THC urinalysis from hemp (Cannabis) seed oil. J. Anal. Toxicol. (1997) 21:319-320.

Campbell, A. M., Evans, M., Thomson, J. L., Williams, M. J.: Cerebral atrophy in young Cannabis smokers. Lancet (1971) 2:1219-1224.

Campbell, D. B.: Extrapolation from animals to man. The integration of pharmacokinetics and pharmacodynamics. Ann. N. Y. Acad. Sci. (1996) 801:116-135.

Chakravarty, I., Sheth, A. R., Ghosh, J. J.: Effect of acute delta 9-tetrahydrocannabinol treatment on serum luteinizing hormone and prolactin levels in adult female rats. Fertil. Steril. (1975) 26:947-948.

Chan, P. C., Sills, R. C., Braun, A. G., Haseman, J. K., Bucher, J. R.: Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fundam. Appl. Toxicol. (1996) 30:109-117.

Chao, F. C., Green, D. E., Forrest, I. S., Kaplan, J. N., Winship-Ball, A., Braude, M.: The passage of 14C-delta-9-tetrahydrocannabinol into the milk of lactating squirrel monkeys. Res. Commun. Chem. Pathol. Pharmacol. (1976) 15:303-317.

Charlebois, A. T., Fried, P. A.: Interactive effects of nutrition and Cannabis upon rat perinatal development. Dev. Psychobiol. (1980) 13:591-605.

Chesher, G. B., Bird, K. D., Jackson, D. M., Perrignon, A., Starmer, G. A.: The effects of orally administered delta 9-tetrahydrocannabinol in man on mood and performance measures: a dose-response study. Pharmacol. Biochem. Behav. (1990) 35:861-864.

Coggins, W. J., Swenson, E. W., Dawson, W. W., Fernandez-Salas, A., Hernandez-Bolanos, J., Jiminez-Antillon, C. F., Solano, J. R., Vinocour, R., Faerron-Valdez, F.: Health status of chronic heavy Cannabis users. Ann. N. Y. Acad. Sci. (1976) 282:148-161.

Cohen, S.: The 94-day Cannabis study. Ann. N. Y. Acad. Sci. (1976) 282:211-220.

Cone, E. J., Johnson, R. E., Moore, J. D., Roache, J. D.: Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol. Biochem. Behav. (1986) 24:1749-1754.

Copeland, K. C., Underwood, L. E., Van Wyk, J. J.: Marihuana smoking and pubertal arrest. J. Pediatr. (1980) 96:1079-1080.

Costantino, A., Schwartz, R. H., Kaplan, P. Hemp oil ingestion causes positive urine tests for delta 9-tetrahydrocannabinol carboxylic acid. J. Anal. Toxicol. (1997) 21:482-485.

Cruickshank, E. K.: Physical assessment of 30 chronic Cannabis users and 30 matched controls. Ann. N. Y. Acad. Sci. (1976) 282:162-167.

Cushman, P., Jr.: Plasma testosterone levels in healthy male marijuana smokers. Am. J. Drug Alcohol Abuse (1975) 2:269-275.

Cushman, P., Grieco, M., Gupta, S.: Reduction in T-lymphocytes forming active rosettes in chronic marijuana smokers. Int. J. Clin. Pharmacol. Biopharm. (1975b) 12:217-220.

Cushman, P., Khurana, R., Hashim, G.: Tetrahydrocannabinol: evidence for reduced rosette formation by normal T lymphocytes. In: Braude, M. C., Szara, S., (eds.): Pharmacology of marihuana. Vol 1. Raven Press, New York 1976. p. 207-209.

Cushman, P., Khurana, R.: Marijuana and T lymphocyte rosettes. Clin. Pharmacol. Ther. (1976) 9:310-317.

Cushman, P., Jr., Khurana, R.: A controlled cycle of tetrahydrocannabinol smoking: T and B cell rosette formation. Life Sci. (1977) 20:971-980.

Daaka, Y., Zhu, W., Friedman, H., Klein, T. W.: Induction of interleukin-2 receptor alpha gene by delta 9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor. DNA Cell Biol. (1997) 16:301-309.

Dahl, R. E., Scher, M. S., Williamson, D. E., Robles, N., Day, N.: A longitudinal study of prenatal marijuana use. Effects on sleep and arousal at age 3 years. Arch. Pediatr. Adolesc. Med. (1995) 149:145-150.

Dax, E. M., Pilotte, N. S., Adler, W. H., Nagel, J. E., Lange, W. R.,: The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function. J. Steroid Biochem. (1989) 34:263-270.

Dax, E. M., Pilotte, N. S., Adler, W. H., Nagel, J. E., Lange, W. R.: Short-term delta 9-tetrahydrocannabinol (THC) does not affect neuroendocrine or immune parameters. NIDA Res. Monogr. (1991) 105:567-568.

Day, N. L., Sambamoorthi, U., Taylor, P., Richardson, G., Robles, N., Jhon, Y., Scher, M., Stopfer, D., Cornelius, M., Jasperse, D.: Prenatal marijuana use and neonatal outcome. Neurotoxicol. Teratol. (1991) 13:329-334.

Derocq, J. M., Segui, M., Marchand, J., Le Fur, G., Casellas, P.: Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. (1995) 369:177-182.

Derungs, R., Känzig, A., Mägert, A.: Qualität von Hanfsamenöl aus der Schweiz. Agrarforschung (1997) 4:451-453.

Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., Mechoulam, R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (1992) 258:1946-1949.

Dewey, W. L.: Cannabinoid pharmacology. Pharmacol. Rev. (1986) 38:151-178.

Di Franco, M. J., Shepard, H. W., Hunter, D. J.: The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco mens’s health study. Ann. Epidemiol. (1996) 6:3283-289.

Di Marzo, V., Fontana, A.: Anandamide, an endogenous cannabinomimetic eicosanoid: ‘killing two birds with one stone’. Prostaglandins Leukot. Essent. Fatty Acids (1995) 53:1-11.

Djeu, J. Y., Wang, M., Friedman, H.: Adverse effect of delta 9-tetrahydrocannabinol on human neutrophil function. Adv. Exp. Med. Biol. (1991) 288:57-62.

Dornbush, R. L., Kolodny, R. C., Baumann, J. E., Webster, S. K.: Human female chronic marijuana use and endocrine functioning. Soc. Neurosci. (1978) Abstr. 4, 490.

Dreher, M. C., Nugent, K., Hudgins, R.: Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study. Pediatrics (1994) 93:254-260.

Dreher, M. C.: Cannabis and pregnancy. In: Mathre, M. L. (ed.): Cannabis in Medical Practice: a Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana. McFarland & Co., Jefferson, NC, 1997. p. 159-170.

Eldridge, J. C., Murphy, L. L., Landfield, P. W.: Cannabinoids and the hippocampal glucocorticoid receptor: recent findings and possible significance. Steroids (1991) 56:226-231.

Ellis, G. M., Jr., Mann, M. A., Judson, B. A., Schramm, N. T., Tashchian, A.: Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin. Pharmacol. Ther. (1985) 38:572-578.

Fairbairn, J. W., Liebmann, J. A., Rowan, M. G.: The stability of Cannabis and its preparations on storage. J. Pharm. Pharmacol. (1976) 28:1-7.

Fischer-Stenger, K., Dove Pettit, D. A., Cabral, G. A.: Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events. J. Pharmacol. Exp. Ther. (1993) 267:1558-1565.

Fleischman, R. W., Hayden, D. W., Rosenkrantz, H., Braude, M. C.: Teratologic evaluation of delta-9-tetrahydrocannabinol in mice, including a review of the literature. Teratology (1975) 12:47-50.

Fortner, N., Fogerson, R., Lindman, D., Iversen, T., Armbruster, D.: Marijuana-positive urine test results from consumption of hemp seeds in food products. J. Anal. Toxicol. (1997) 21:476-481.

Fried, P. A.: Marihuana use by pregnant women: neurobehavioral effects in neonates. Drug Alcohol Depend. (1980) 6:415-424.

Fried, P. A., Watkinson, B., Willan, A.: Marijuana use during pregnancy and decreased length of gestation. Am. J. Obstet. Gynecol. (1984) 150:23-27.

Fried, P. A., O’Connell, C. M.: A comparison of the effects of prenatal exposure to tobacco, alcohol, Cannabis and caffeine on birth size and subsequent growth. Neurotoxicol. Teratol. (1987) 9:79-85.

Fried, P. A., Watkinson, B., Dillon, R.F., Dulberg, C. S.: Neonatal neurological status in a low-risk population after prenatal exposure to cigarettes, marijuana and alcohol. J. Dev. Behav. Pediatr. (1987b) 8:318-326.

Fried, P. A.: Prenatal exposure to marihuana and tobacco during infancy, early and middle childhood: effects and an attempt at synthesis. Arch. Toxicol. Suppl. (1995) 17:233-260.

Fried, P. A., Watkinson, B., Siegel, L. S.: Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana. Neurotoxicol. Teratol. (1997) 19:171-183.

Friedman, H.: Suppression by cannabinoids of a cloned cell line with natural killer cell activity. Proc. Soc. Exp. Biol. Med. (1988) 187:355-359.

Friedman, M., Cepero, M. L., Klein, T., Friedman, H.: Suppressive effect of delta 9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages. Proc. Soc. Exp. Biol. Med. (1986) 182:225-228.

Friedrich, G., Nepita, W., Andre, T.: Serumtestosteronkonzentrationen bei Cannabis- und Opiatkonsumenten. Beitr. Gerichtl. Med. (1990) 48:57-66.

Frytak, S., Moertel, C. G., O’Fallon, J. R., Rubin, J., Creagan, E. T., O’Connell, M. J., Schutt, A. J., Schwartau, N. W.: Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a plazebo. Ann. Intern. Med. (1979) 91:825-830.

Frytak, S., Moertel, C. G., Rubin, J.: Metabolic studies of delta-9-tetrahydrocannabinol in cancer patients.: Cancer Treat. Rep. (1984) 68:1427-1431.

Garcia-Gil, L., De Miguel, R., Munoz, R. M., Cebeira, M., Villanua, M. A., Ramos, J. A., Fernandez-Ruiz, J. J.: Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats. Neurotoxicol. Teratol. (1997) 19:477-487.

Gibson, G. T., Baghurst, P. A., Colley, D. P.: Maternal alcohol, tobacco and Cannabis consumption and the outcome of pregnancy. Aust. N. Z. J. Obstet. Gynaecol. (1983) 23:15-19.

Greenland, S., Richwald, G. A., Honda, G. D.: The effects of marijuana use during pregnancy. II. A study in a low-risk home-delivery population. Drug Alcohol Depend. (1983) 11:359-366.

Greenland, S., Staisch, K. J., Brown, N., Gross, S. J.: The effects of marijuana use during pregnancy. I. A preliminary epidemiologic study. Am. J. Obstet. Gynecol. (1982) 143:408-413.

Gruber, A. J., Pope, H. G., Jr., Oliva, P.: Very long-term users of marijuana in the United States: a pilot study. Subst. Use Misuse (1997) 32:249-264.

Guy, R. H.: Percutaneous absorption: physical chemistry meets the skin. Curr. Probl. Dermatol. (1995) 22:132-138.

Hadgraft, J.: Recent developments in topical and transdermal delivery. Eur. J. Drug Metab. Pharmacokinet. (1996) 21:165-173.

Hall, W., Solowij, N., Lemon, J.: The Health and Psychological Consequences of Cannabis Use. Commonwealth Department of Human Services and Health, Monograph Series No. 25, Canberra 1994.

Hall, W., Room, R., Bondy, S.: A comparative appraisal of the health and psychological consequences of alcohol, Cannabis, nicotine and opiate use. Addiction Research Foundation, Toronto/Canada 1994b.

Harclerode, J., Bird, L., Sawyer, H., Berger, W., Mooney, R., Smith, R.: Sex hormone levels in adult rats injected with delta-9-tetrahydrocannabinol and phencyclidine. In: Agurell, S., Dewey, W. L., Willette, R. E. (eds.): The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects. Academic Press, New York 1984. p. 441-452.

Harclerode, J.: Endocrine effects of marijuana in the male: preclinical studies. NIDA Res. Monogr. (1984) 44:46-64.

Harmon, J., Aliapoulios, M. A.: Gynecomastia in marihuana users. N. Engl. J. Med. (1972) 287:936.

Harvey, D. J., Brown, N. K.: Comparative in vitro metabolism of the cannabinoids. Pharmacol. Biochem. Behav. (1991) 40:533-540.

Harvey, D. J.: Metabolism and pharmacokinetics of the cannabinoids. In: Watson, R. R. (ed.): Biochemistry and Physiology of Substance Abuse. Volume III. Boca Raton, Florida 1991. p. 279-365.

Hatch, E. E., Bracken, M. B.: Effect of marijuana use in pregnancy on fetal growth. Am. J. Epidemiol. (1986) 124:986-993.

Hembree, W. C., 3d., Zeidenberg, P., Nahas, G. G.: Marihuana’s effects on human gonadal function. In: Nahas, G. G., et al., (eds.): Marihuana: chemistry, biochemistry, and cellular effects. Springer, New York 1976. p. 521-532.

Hembree, W. C., 3d., Nahas, G. G., Zeidenberg, P., Huang, H. F.: Changes in human spermatozoa associated with high dose marihuana smoking. Adv. Biosci. (1978) 22-23:429-439.

Hemminki, K., Vineis, P.: Extrapolation of the evidence on teratogenicity of chemicals between humans and experimental animals: chemicals other than drugs. Teratog. Carcinog. Mutagen. (1985) 5:251-318.

Hernandez, M. L., Garcia-Gil, L., Berrendero, F., Ramos, J. A., Fernandez-Ruiz, J. J.: delta 9-tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons. J. Mol. Neurosci. (1997) 8:83-91.

Hillard, C. J., Farber, N. E., Hagen, T. C., Bloom, A. S.: The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the rat. Pharmacol. Biochem. Behav. (1984) 20:547-550.

Hingson, R., Alpert, J. J., Day, N., Dooling, E., Kayne, H., Morelock, S., Oppenheimer, E., Zuckerman, B.: Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics (1982) 70:539-546.

Hollister, L. E., Moore, F., Kanter, S., Noble, E.: Delta-1-tetrahydrocannabinol, synhexyl and marijuana extract administered orally in man: catecholamine excretion, plasma cortisol levels and platelet serotonin content. Psychopharmacologia (1970) 17:354-360.

Hollister, L. E., Reaven, G. M.: Delta-9-tetrahydrocannabinol and glucose tolerance. Clin. Pharmacol. Ther. (1974) 16:297-302.

Hollister, L. E.: Health aspects of Cannabis. Pharmacol. Rev. (1986) 38:1-20.

Hollister, L. E.: Marijuana and immunity. J. Psychoactive Drugs (1992) 24:159-164.

Howlett, A. C.: Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. (1995) 35:607-634.

Hutchings, D. E., Brake, S., Morgan, B., Lasalle, E., Shi, T. M.: Developmental toxicity of prenatal delta-9-tetrahydrocannabinol: effects of maternal nutrition, offspring growth, and behavior. NIDA Res. Monogr. (1987) 76:363-369.

Hutchings, D. E., Martin, B. R., Gamagaris, Z., Miller, N., Fico, T.: Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. (1989) 44:697-701.

Hutchings, D. E., Dow-Edwards, D.: Animal models of opiate, cocaine, and Cannabis use. Clin. Perinatol. (1991) 18:1-22.

Ings, R. M.: Interspecies scaling and comparison in drug development and and toxicokinetics. Xenobiotica (1990) 20:1201-1231.

Jackson, A. L., Murphy, L. L.: Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol. Neuroendocrinology (1997) 65:446-452.

Jorgensen, K., Wulf, H. C., Husum, B., Niebuhr, E., Jrgensen, K.: Sister-chromatid exchanges in Cannabis smokers. Mutat. Res. (1991) 261:193-195.

Kaklamani, E., Trichopoulos, D., Koutselinis, A., Drouga, M., Karalis, D.: Hashish smoking and T-lymphocytes. Arch. Toxicol. (1978) 40:97-101.

Kalbitz, J., Neubert, R., Wohlrab, W.: Modulation der Wirkstoffpenetration in die Haut. Pharmazie (1996) 51:619-637.

Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., Kessler, F. K.: Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. (1994) 48:1899-1908.

Kaslow, R. A., Blackwelder, W. C., Ostrow, D. G., Yerg, D., Palenick, J., Coulson, A. H., Valdisseri, R. O.: No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodefiency in HIV-1-positive individuals: A report from the Multicenter AIDS cohort Study. JAMA (1989) 261:3424-3429.

Kawakami, Y., Klein, T. W., Newton, C., Djeu, J. Y., Specter, S., Friedman, H.: Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. Int. J. Immunopharmacol. (1988) 10:485-488.

Kawash, G. F., Yeung, D. L., Berg, S. D.: Effects of administration of Cannabis resin during pregnancy on emotionality and learning in rats’ offspring. Percept. Mot. Skills (1980) 50:359-365.

Keplinger, M. L.: The effect of natural and synthetic delta-9-tetrahydrocannabinol on reproductive and lactation performance in albino rats. Toxicol. Appl. Pharmacol. (1973) 25:449.

Klein, T. W., Newton, C. A., Widen, R., Friedman, H.: The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses. J. Immunopharmacol. (1985) 7:451-466.

Klein, T. W., Newton, C., Friedman, H.: Inhibition of natural killer cell function by marijuana components. J. Toxicol. Environ. Health (1987) 20:321-332.

Klein, T. W., Newton, C., Widen, R., Friedman, H.: Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J. Pharmacol. Exp. Ther. (1993) 267:635-640.

Knight, E. M., James, H., Edwards, C. H., Spurlock, B. G., Oyemade, U. J., Johnson, A. A., West, W. L., Cole, O. J., Westney, L. S., Westney, O. E.: Relationships of serum illicit drug concentrations during pregnancy to maternal nutritional status. J. Nutr. (1994) 124:973S-980S.

Kolodny, R. C., Masters, W. H., Kolodner, R. M., Toro, G.: Depression of plasma testosterone levels after chronic intensive marihuana use. N. Engl. J. Med. (1974) 290:872-874.

Kolodny R. C., Webster, W. H., Tullman, G. D., Dornbush, R. I.: Chronic marihuana use by women: Menstrual cycle and endocrine findings. Presented at the New York Postgraduate Medicinal School Second Annual Conference on Marihuana, June 28-29, 1979. Zitiert nach: Abel 1981.

Kumar, M. S., Chen, C. L.: Effect of an acute dose of delta 9-THC on hypothalamic luteinizing hormone releasing hormone and met-enkephalin content and serum levels of testosterone and corticosterone in rats. Subst. Alcohol Actions Misuse (1983) 4:37-43.

Kusher, D. I., Dawson, L. O., Taylor, A. C., Djeu, J. Y.: Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell. Immunol. (1994) 154:99-108.

Lau, R. J., Tubergen, D. G., Barr, M., Jr., Domino, E. F., Benowitz, N., Jones, R. T.: Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta-9-tetrahydrocannabinol. Science (1976) 192:805-807.

Lefkowitz, S. S., Klager, K., Nemeth, D., Pruess, M.: Immunosuppression of mice by delta-9-tetrahydrocannabinol. Res. Commun. Chem. Pathol. Pharmacol. (1978) 19:101-107.

Lehmann, T., Sager, F., Brenneisen, R.: Excretion of cannabinoids in urine after ingestion of Cannabis seed oil. J. Anal. Toxicol. (1997) 21:373-375.

Leuschner, J. T., Harvey, D. J., Bullingham, R. E., Paton, W. D.: Pharmacokinetics of delta 9-tetrahydrocannabinol in rabbits following single or multiple intravenous doses. Drug Metab. Dispos. (1986) 14:230-238.

Levy, J. A., Heppner, G. H.: Alterations in murine delayed type hypersensitivity responses by delta-8-THC and cannabinol. J. Immunopharmacol. (1978-79) 1:105-114.

Levy, J. A., Heppner, G. H.: Alterations of immune reactivity by haloperidol and delta-9-tetrahydrocannabinol. J. Immunopharmacol. (1981) 3:93-109.

Levy, M., Koren, G.: Obstetric and neonatal effects of drugs of abuse. Emerg. Asp. Drug Abuse (1990) 8:633-652.

Lindgren, J. E., Ohlsson, A., Agurell, S., Hollister, L., Gillespie, H.: Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of Cannabis. Psychopharmacology (Berl.) (1981) 74:208-212.

Linn, S., Schoenbaum, S. C., Monson, R. R., Rosner, R., Stubblefield, P. C., Ryan, K. J.: The association of marijuana use with outcome of pregnancy. Am. J. Public Health (1983) 73:1161-1164.

Lopez-Cepero, M., Friedman, M., Klein, T., Friedman, H.: Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J. Leukoc. Biol. (1986) 39:679-686.

Loveless, S. E., Harris, L. S., Munson, A. E.: Hyporesponsiveness to the immunosuppressant effects of delta-8-tetrahydrocannabinol. J. Immunopharmacol. (1981-82) 3:371-383.

Lu, F., Ou, D. W.: Cocaine or delta 9-tetrahydrocannabinol does not affect cellular cytotoxicity in vitro. Int. J. Immunopharmacol. (1989) 11:849-852.

Lu, F.: Effect of cocaine and marijuana on cellular immunity. Diss. Abstr. Int. (1990) 50:4462.

Luo, Y. D., Patel, M. K., Wiederhold, M. D., Ou, D. W.: Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. Int. J. Immunopharmacol. (1992) 14:49-56.

Luthra, Y. K., Esber, H. J., Lariviere, D. M., Rosenkrantz, H.: Assessment of tolerance to immunosuppressive activity of delta 9-tetrahydrocannabinol in rats. J. Immunopharmacol. (1980) 2:245-256.

Markianos, M., Stefanis, C.: Effects of acute Cannabis use and short-term deprivation on plasma prolactin and dopamine-beta-hydroxylase in long-term users. Drug Alcohol Depend. (1982) 9:251-255.

Martin, B. R., Dewey, W. L., Harris, L. S., Beckner, J. S.: 3H-delta 9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses. Res. Commun. Chem. Pathol. Pharmacol. (1977) 17:457-470.

Martin, B. R.: Cellular effects of cannabinoids. Pharmacol. Rev. (1986) 38:45-74.

Matsuda, L. A.: Molecular aspects of cannabinoid receptors. Crit. Rev. Neurobiol. 11, 143-166 (1997).

Matsuyama, S. S., Jarvik, L. F., Fu, T. K., Yen, F. S.: Chromosome studies before and after supervised marijuana smoking. In: Braude, M. C., Szara, S., (eds.): Pharmacology of marihuana. Vol 2. New York, Raven Press, 1976. p. 723-729.

Matsuyama, S. S., Fu, T. K.: In vivo cytogenetic effects of cannabinoids. J. Clin. Psychopharmacol. (1981) 1:135-140.

Mattie, D. R., Grabau, J. H., McDougal, J. N.: Significance of the dermal route of exposure to risk assessment. Risk Anal. (1994) 14:277-284.

Maykut, M. O.: Health consequences of acute and chronic marihuana use. Prog. Neuropsychopharmacol. Biol. Psychiatry (1985) 9:209-238.

Mechoulam, R. (1986): The pharmacohistory of Cannabis sativa. In: Mechoulam, R. (ed.): Cannabinoids as therapeutic agents. CRC Press, Boca Raton (US/Florida) 1986.

Mechoulam, R., Shabat, S. B., Hanus, L., Fride, E., Bayewitch, M., Vogel, Z.: Endogenous cannabinoid ligands. Adv. Exp. Med. Biol. (1996) 402:95-101.

Mendelson, J. H., Kuehnle, J., Ellingboe, J., Babor, T. F.: Plasma testosterone levels before, during and after chronic marihuana smoking. N. Engl. J. Med. (1974) 291:1051-1055.

Mendelson, J. H., Ellingboe, J., Kuehnle, J. C., Mello, N. K.: Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J. Pharmacol. Exp. Ther. (1978) 207:611-617.

Mendelson, J. H., Mello, N. K.: Effects of marijuana on neuroendocrine hormones in human males and females. NIDA Res. Monogr. (1984) 44:97-114.

Mendelson, J. H., Cristofaro, P., Ellingboe, J., Benedikt, R., Mello, N. K.: Acute effects of marihuana on luteinizing hormone in menopausal women. Pharmacol. Biochem. Behav. (1985) 23:765-768.

Mendelson, J. H., Mello, N. K., Ellingboe, J.: Acute effects of marihuana smoking on prolactin levels in human females. J. Pharmacol. Exp. Ther. (1985b) 232:220-222.

Mendelson, J. H., Mello, N. K., Ellingboe, J., Skupny, A. S., Lex, B. W., Griffin, M.: Marihuana smoking suppresses luteinizing hormone in women. J. Pharmacol. Exp. Ther. (1986) 237:862-866.

Mishkin, E. M., Cabral, G. A.: delta 9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse. J. Gen. Virol. (1985) 66:2539-2549.

Morahan, P. S., Klykken, P. C., Smith, S. H., Harris, L. S., Munson, A. E.: Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect. Immun. (1979) 23:670-674.

Mordenti, J.: Man versus beast: Pharmacokinetic scaling in mammals. J. Pharm. Sci. (1986) 75:1028-1040.

Morrill, G. A., Kostellow, A. B., Ziegler, D. H., Fujimoto, G. I.: Effects of cannabinoids on function of testis and secondary sex organs in the Fischer rat. Pharmacology (1983) 26:20-28.

Munson, A. E., Levy, J. A., Harris, L. S., Dewey, W. L.: Effects of delta 9-tetrahydrocannabinol on the immune system. In: Braude, M. C., Szara, S., (eds.): Pharmacology of marihuana. Vol 1. Raven Press, New York 1976. p. 187-197.

Munson, A. E., Fehr, K. O.: Immunological effects of Cannabis. In: Fehr, K. O., Kalant, H. (eds.): Cannabis and Health Hazards. Addiction Research Foundation, Toronto 1983.

Nahas, G. G., Morishima, A., Desoize, B.: Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes. Fed. Proc. (1977) 36:1748-1752.

Nahas, G. G., Suciu-Foca, N., Armand, J. P., Morishima, A.: Inhibition of cellular mediated immunity in marihuana smokers. Science (1974) 183:419-420.

Nahas, G. G.: Toxikology and pharmacology. In: Nahas, G. G.: Marihuana in science and medicine. Raven Press, New York 1984.

Nakano, Y., Pross, S. H., Friedman, H.: Modulation of interleukin 2 activity by delta 9-tetrahydrocannabinol after stimulation with concavalin A, phytohemagglutinin, or anti-CD3 antibody. Proc. Soc. Exp. Biol. Med. (1992) 201:165-168.

Navarro, M., Rubio, P., de Fonseca, F. R.: Behavioural consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology (Berl.) (1995) 122:1-14.

O’Connell, C. M., Fried, P. A.: An investigation of prenatal Cannabis exposure and minor physical anomalies in a low risk population. Neurobehav. Toxicol. Teratol. (1984) 6:345-350.

Ohlsson, A., Lindgren, J. E., Wahlen, A., Agurell, S., Hollister, L. E., Gillespie, H. K.: Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin. Pharmacol. Ther. (1980) 28:409-416.

Ostrea, E. M., Jr., Ostrea, A. R., Simpson, P. M.: Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation. Pediatrics (1997) 100:79-83.

Patel, V., Borysenko, M., Kumar, M. S., Millard, W. J.: Effects of acute and subchronic delta 9-tetrahydrocannabinol administration on the plasma catecholamine, beta-endorphin, and corticosterone levels and splenic natural killer cell activity in rats. Proc. Soc. Exp. Biol. Med. (1985) 180:400-404.

Patrini, G., Sacerdote, P., Fuzio, D., Manfredi, B., Parolaro, D.: Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound. J. Neuroimmunol. (1997) 80:143-148.

Perez-Reyes, M., Di Guiseppi, S., Davis, K. H., Schindler, V. H., Cook, C. E.: Comparison of effects of marihuana cigarettes to three different potencies. Clin. Pharmacol. Ther. (1982) 31:617-624.

Perez-Reyes, M., Wall, M. E.: Presence of delta 9-tetrahydrocannabinol in human milk. N. Engl. J. Med. (1982) 307:819-820.

Perez-Reyes, M., Di Guiseppi, S., Mason, A. P., Davis, K. H.: Passive inhalation of marihuana smoke and urinary excretion of cannabinoids. Clin. Pharmacol. Ther. (1983) 34:36-41.

Permutt, M. A., Goodwin, D. W., Schwin, R., Hill, S. Y.: The effect of marijuana on carbohydrate metabolism. Am. J. Psychiatry (1976) 133:220-224.

Pertwee, R. G.: Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of Cannabis extract or delta1-tetrahydrocannabinol. Br. J. Pharmacol. (1974) 51:391-397.

Pertwee, R.: Cannabinoid Receptors. Academic Press, London 1995.

Petersen, B. H., Graham, J., Lemberger, L.: Marihuana, tetrahydrocannabinol and T-cell function. Life Sci. (1976) 19:395-400.

Pisacane, A.: Effects of maternal marijuana and cocaine use on fetal growth. N. Engl. J. Med. (1989) 321:979.

Pross, S. H., Nakano, Y., McHugh, S., Widen, R., Klein, T. W., Friedman, H.: Contrasting effects of THC on adult murine lymph node and spleen cell populations stimulated with mitogen or anti-CD3 antibody. Immunopharmacol. Immunotoxicol. (1992) 14:675-687.

Rachelefsky, G. S., Opelz, G., Mickey, M. R., Lessin, P., Kiuchi, M., Silverstein, M. J., Stiehm, E. R.: Intact humoral and cell-mediated immunity in chronic marijuana smoking. J. Allergy Clin. Immunol. (1976) 58:483-490.

Rachelefsky, G. S., Opelz, G.: Normal lymphocyte function in the presence of delta-9-tetrahydrocannabinol. Clin. Pharmacol. Ther. (1977) 21:44-46.

Relman, A. S. (ed.): Marijuana and Health. National Academy Press, Institute of Medicine, Washington DC 1982.

Richardson, G. A., Day, N. L., Goldschmidt, L.: Prenatal alcohol, marijuana, and tobacco use: infant mental and motor development. Neurotoxicol. Teratol. (1995) 17:479-487.

Romero, J., Berrendero, F., Garcia-Gil, L., De La Cruz, P., Ramos, J. A., Fernández-Ruiz, J.J.: Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5′-O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience (1998) 84:1075-1083.

Romero, J., Garcia-Palomero, E., Castro, J. G., Garcia-Gil, L., Ramos, J. A., Fernandez-Ruiz, J. J.: Effects of chronic exposure to delta-9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res. Mol. Brain Res. (1997) 46:100-108.

Rosenkrantz, H., Miller, A. J., Esber, H. J.: delta 9-tetrahydrocannabinol suppression of the primary immune response in rats. J. Toxicol. Environ. Health (1975) 1:119-125.

Sanchez, C., Velasco, G., Guzman, M.: Metabolic stimulation of mouse spleen lymphocytes by low doses of delta-9-tetrahydrocannabinol. Life Sci. (1997) 60:1709-1717.

Scallet, A. C.: Neurotoxicology of Cannabis and THC: a review of chronic exposure studies in animals. Pharmacol. Biochem. Behav. (1991) 40:671-676.

Schaefer, C. F., Gunn, C. G., Dubowski, K. M.: Normal plasma testosterone concentrations after marihuana smoking. N. Engl. J. Med. (1975) 292:867-868.

Schatz, A. R., Koh, W. S., Kaminski, N. E.: Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacology (1993) 26:129-137.

Scher, M. S., Richardson, G. A., Coble, P. A., Day, N. L., Stoffer, D. S.: The effects of prenatal alcohol and marijuana exposure: Disturbances in neonatal sleep cycling and arousal. Pediatr. Res. (1988) 24:101-105.

Schwartzfarb, L., Needle, M., Chavez-Chase, M.: Dose-related inhibition of leukocyte migration by marihuana and delta-9-tetrahydrocannabinol (THC) in vitro. J. Clin. Pharmacol. (1974) 14:35-41.

Segelman, A. B., Segelman, F. P.: Possible noninhibition of cellular-mediated immunity in marihuana smokers. Science (1974) 185:543-544.

Shiono, P. H., Klebanoff, M. A., Nugent, R. P., Cotch, M. F., Wilkins, D. G., Rollins, D. E., Carey, J. C., Behrman, R. E.: The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am. J. Obstet. Gynecol. (1995) 172:19-27.

Shivers, S. C., Newton, C., Friedman, H., Klein, T. W.: delta 9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines. Life Sci. (1994) 54:1281-1289.

Sidney, S., Beck, J. E., Tekawa, I. S., Quesenberry, C. P., Friedman, G. D.: Marijuana use and mortality. Am. J. Public Health (1997) 87:585-590.

Silverstein, M. J., Lessin, P. J.: Normal skin test responses in chronic marijuana users. Science (1974) 186:740-741.

Smith, C. G., Almirez, R. G., Berenberg, J., Asch, R. H.: Tolerance develops to the disruptive effects of delta 9-tetrahydrocannabinol on primate menstrual cycle. Science (1983) 219:1453-1455.

Smith, C. G., Asch, R. H.: Acute, short-term, and chronic effects of marijuana on the female primate reproductive function. NIDA Res. Monogr. (1984) 44:82-96.

Smith, M. S., Yamamoto, Y., Newton, C., Friedman, H., Klein, T.: Psychoactive cannabinoids increase mortality and alter acute phase cytokine responses in mice sublethally infected with Legionella pneumophila. Proc. Soc. Exp. Biol. Med. (1997) 214:69-75.

Smith, S. H., Harris, L. S., Uwaydah, I. M., Munson, A. E.: Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity. J. Pharmacol. Exp. Ther. (1978) 207:165-170.

Solowij, N., Grenyer, B. F., Chesher, G., Lewis, J.: Biopsychosocial changes associated with cessation of Cannabis use: a single case study of acute and chronic cognitive effects, withdrawal and treatment. Life Sci. (1995) 56:2127-2134.

Specter, S. C., Klein, T. W., Newton, C., Mondragon, M., Widen, R., Friedman, H.: Marijuana effects on immunity: suppression of human natural killer cell activity of delta-9-tetrahydrocannabinol. Int. J. Immunopharmacol. (1986) 8:741-745.

Specter, S., Lancz, G., Westrich, G., Friedman, H.: delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int. J. Immunopharmacol. (1991) 13:411-417.

Specter, S., Lancz, G. Effects of marijuana on human natural killer cell activity. Adv. Exp. Med. Biol. (1991b) 288:47-56.

Starks, M.: Marijuana chemistry. Genetics, Processing & Potency. Ronin Publishing Inc., Berkeley, California 1990.

Stefanis, C.: Biological aspects of Cannabis use. NIDA Res. Monogr. (1978) 19:149-178.

Stella, N., Schweitzer, P., Piomelli, D.: A second endogenous cannabinoid that modulates long-term potentiation. Nature (1997) 388:773-778.

Struempler, R. E., Nelson, G., Urry, F. M.: A positive cannabinoids workplace drug test following the ingestion of commercially available hemp seed oil. J. Anal. Toxicol. (1997) 21:283-285.

Sulcova, E., Mechoulam, R., Fride, E.: Biphasic effects of anandamide. Pharmacol. Biochem. Behav. (1998) 59:347-352.

Tahir, S. K., Trogadis, J. E., Stevens, J. K., Zimmerman, A. M.: Cytoskeletal organization following cannabinoid treatment in undifferentiated and differentiated PC12 cells. Biochem. Cell. Biol. (1992) 70:1159-1173.

Tennes, K.: Effects of marijuana on pregnancy and fetal development in the human. NIDA Res. Monogr. (1984) 44:115-123.

Tennes, K., Avitable, N., Blackard, C., Boyles, C., Hassoun, B., Holmes, L., Kreye, M.: Marijuana: prenatal and postnatal exposure in the human. NIDA Res. Monogr. (1985) 59:48-60.

Thompson, G. R., Rosenkrantz, H., Schaeppi, U. H., Braude, M. C.: Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys. Toxicol. Appl. Pharmacol. (1973) 25:363-372.

Turner, C. E., Elsohly, M. A., Boeren, E. G.: Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J. Nat. Prod. (1980) 43:169-234.

Tyrey, L., Murphy, L. L.: Effects of delta-9-tetrahydrocannabinol on reproductive neuroendocrine function in the female: animal studies. NIDA Res. Monogr. (1984) 55:42-51.

Uyeno, E. T.: Delta-9-tetrahydrocannabinol administered during pregnancy of the rat. Proceed. West Pharmacol. Soc. (1973) 16:64-67.

Verbraucherzentrale (Central Consumer council) Hamburg: Alkohol in Lebensmitteln (Alcohol in food). Brochure, 12/1996.

Vescovi, P. P., Pedrazzoni, M., Michelini, M., Maninetti, L., Bernardelli, F., Passeri, M.: Chronic effects of marijuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males. Drug Alcohol Depend. (1992) 30:59-63.

Voisin, E. M., Ruthsatz, M., Collins, J.M., Hoyle, P.C.: Extrapolation of animal toxicity to humans: interspecies comparison in drug development. Regul. Toxicol. Pharmacol. (1990) 12:107-116.

Wall, M. E., Sadler, B. M., Brine, D., Taylor, H., Perez-Reyes, M.: Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin. Pharmacol. Ther. (1983) 34:352-363.

Wallace, J.M., Tashkin, D. P., Oishi, J. S.: Peripheral blood lymphocytes subpopulations and mitogen responsiveness in tobacco and marijuana smokers. J. Psychactive Drugs (1988) 20:9-14.

Watzl, B., Scuderi, P., Watson, R. R.: Influence of marijuana components (THC and CBD) on human mononuclear cell cytokine secretion in vitro. Adv. Exp. Med. Biol. (1991) 288:63-70.

White, S. C., Brin, S. C., Janicki, B. W.: Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers. Science (1975) 188:71-72.

WHO: Cannabis a Health Perspective and Research Agenda. Division of Mental Health and Prevention of Substance Abuse. World Health Organization, Genf 1997.

Winneke, G., Lilienthal, H.: Extrapolation from animals to humans: scientific and regulatory aspects. Toxicol. Lett. (1992) 64-65:239-246.

Witter, F. R., Niebyl, J.R.: Marijuana use in pregnancy and pregnancy outcome. Am. J. Perinatol. (1990) 7:36-38.

Zimmer, B. D., Bickel, P., Dittrich, A.: Changes of simple somatic parameters by delta-9-trans-tetrahydrocannabinol (delta-9-THC) in a double-blind-study. Short communication. Arzneimittelforschung (1976) 26:1614-1616.

Zimmer, L., Morgan, J.P.: Marijuana Myths, Marijuana Facts. A Review of the Scientific Evidence. The Lindesmith Center, New York/San Francisco 1997.

Zimmerman, A. M., Bruce, W. R., Zimmerman, S.: Effects of cannabinoids on sperm morphology. Pharmacology (1979) 18:143-148.

Zimmerman, S., Zimmerman, A. M., Cameron, I. L., Laurence, H. L.: Delta1-tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice. Pharmacology (1977) 15:10-23.

Zuckerman, B., Frank, D. A., Hingson, R., Amaro, H., Levenson, S. M., Kayne, H., Parker, S., Vinci, R., Aboagye, K., Fried, L. E.: Effects of maternal marijuana and cocaine use on fetal growth. N. Engl. J. Med. (1989) 320:762-768.

You Missed